Mounjaro®
Starting from £179.99/mo
Start journey Learn moreAshwagandha is not known to have a clinically significant interaction with semaglutide (Wegovy), but the evidence base is thin and the question deserves a straight answer. Wegovy is a prescription-only medicine; any supplement you take alongside it is worth discussing with the prescriber overseeing your treatment. Ashwagandha is a traditional herbal adaptogen that does not appear in Wegovy's formal contraindication list, yet that absence of evidence is not the same as a green light — particularly for anyone managing thyroid conditions, blood pressure or blood sugar, where ashwagandha can have its own pharmacological effects.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
No published clinical study has directly examined ashwagandha and semaglutide taken together, and the Wegovy Summary of Product Characteristics does not list ashwagandha as a contraindicated substance. That makes this a grey area rather than a red one, but grey areas still deserve care. The NHS semaglutide medicines page advises telling your prescriber and pharmacist about all supplements and herbal remedies you take before starting treatment, precisely because the interaction picture with complementary products is rarely fully mapped.
Ashwagandha (Withania somnifera) is classed as an adaptogen. In research settings it has shown effects on cortisol, thyroid-stimulating hormone, fasting blood glucose and blood pressure, none of these effects are dramatic enough to make the combination obviously dangerous, but they do mean the supplement is not entirely inert in ways that could overlap with semaglutide's territory.
The practical upshot: telling your prescriber you take ashwagandha takes thirty seconds and removes the uncertainty. On a Wegovy treatment pathway, that conversation happens naturally at the consultation stage, where your full health picture is reviewed before a prescription is issued.
This is a question our prescribers hear most weeks in one form or another, not always about ashwagandha specifically, but about supplements and timing in general. Semaglutide slows gastric emptying as part of how it reduces appetite, and that slowing can affect how quickly oral products move through the stomach into the small intestine where absorption happens. For most food-derived supplements the practical effect is modest. For medicines with narrow therapeutic windows it matters more.
Ashwagandha is typically taken as a root extract capsule or powder. Its active compounds (withanolides) are not time-sensitive in the way that a thyroid tablet or an oral contraceptive is. That said, if you take ashwagandha at the same time as other oral medicines, the slowed transit is worth mentioning, particularly if you are also on HRT or any blood-pressure or blood-sugar medication, where precise absorption matters more. The Wegovy Patient Information Leaflet, available via the electronic Medicines Compendium, covers the gastric-emptying effect and how it applies to concomitant oral medicines.
The honest position: ashwagandha absorption is probably not meaningfully impaired by Wegovy's gastric-emptying effect, but the reverse question (whether ashwagandha's physiological actions interact with semaglutide's) is less easy to dismiss.
Three areas are worth understanding clearly.
Blood glucose. Ashwagandha has shown modest hypoglycaemic effects in small trials. Wegovy itself is not a glucose-lowering medicine in the way that insulin is, but weight loss on semaglutide does tend to improve insulin sensitivity over time. For most people this combination of effects is not a concern. For anyone managing type 2 diabetes or prediabetes alongside their weight treatment, an unexpected dip in blood sugar is worth monitoring, a conversation covered in any thorough clinical review. People exploring their weight-loss options often don't realise how much the prescriber assessment covers beyond the basics.
Thyroid hormones. A small number of human trials suggest ashwagandha can raise T3 and T4 levels modestly. Wegovy does not directly affect the thyroid, but thyroid status does affect weight regulation. Anyone with a thyroid condition, or who takes levothyroxine, should mention ashwagandha use to their prescriber. For broader context on how other conditions interact with semaglutide therapy, our page on MS and Wegovy illustrates the kind of multi-condition nuance a clinical review picks up.
Blood pressure. Ashwagandha is associated with small reductions in systolic blood pressure in some studies. Wegovy, through weight loss, can also bring blood pressure down over time. Combined reductions are unlikely to be dramatic, but if you are already on antihypertensive medication the full picture should be on your prescriber's radar. If your diet is also a focus during treatment, it is worth reading about Wegovy and MASH, which covers how metabolic and dietary factors are considered alongside semaglutide therapy.
None of these mean you cannot take ashwagandha and Wegovy together. They mean the combination deserves transparency rather than assumption.
Tell your prescriber. That is not a bureaucratic answer, it is the practical one. A clinical review before starting Wegovy is designed to capture exactly this kind of information: your current medications, your supplements, your relevant medical history. At nume, every consultation is read by a GPhC-registered Independent Prescriber, not processed by automated software; if you list ashwagandha as a supplement you take, it gets noted and considered in the context of your health profile.
If you are already on Wegovy and have started taking ashwagandha since your last review, contact your prescriber or pharmacy. For questions about how supplements interact with your treatment, the B12 and Wegovy page covers a related example of how nutritional status is factored into ongoing semaglutide care. You can also look at the cost and what's included in private treatment if you want to understand what aftercare support looks like practically.
If you have concerns and want to speak to someone directly, our team is reachable seven days a week. And if you are not yet on Wegovy but weighing up whether it is right for you, a free consultation with our prescribers is the natural starting point.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.